Toxicology Faciliites
Chengdu, Sichuan, China

Corporate Headquarters
20251 Century Blvd.
Suite 325
Germantown, MD 20874
U.S.A.

Phone: (301) 515-5560
Fax: (301) 515-5562

Frontier BioSciences Appoints Mark Walker a Senior Post at its China Facility

Germantown, MD – March 2010 – Frontier is pleased to announce the addition of Mark D. Walker, DVM as Vice President of Toxicology, Pathology, and Laboratory Animal Medicine. With more than 20 years of experience from major U.S. CROs, Hazleton/Covance and Charles River’s Sierra Biomedical in Reno, NV, Dr. Walker brings a wealth of knowledge and expertise in scientific direction, training and development, and management of nonclinical contract services.

With his current position, Dr. Walker will further expand upon and broaden Frontier’s extensive experience and knowledge of U.S. CRO standards and practices, especially in the areas of primate toxicology, infusion techniques in multiple species, surgical support, and animal model development, and contribute to the modernization of China’s rapidly-emerging market for drug safety and development.

“Mark’s toxicology and lab animal medicine experience, along with his U.S. CRO background and his enthusiasm for business challenges and team-based success, will serve him well at Frontier here in Chengdu,” said Dr. Dong Xie, CEO of Frontier. “His experience in business development, professional advancement, and customer management will be a valuable asset as well.”

Dr. Walker earned his degrees in Doctor of Veterinary Medicine and B.S. in Veterinary Science from Texas A&M University in College Station, Texas. He completed a postdoctoral residency in Comparative Pathobiology and Primate Medicine/Surgery from Bowman Grey School of Medicine prior to joining Hazleton Laboratories in Vienna, Virginia, in 1990.

About Frontier BioSciences, Inc.

Frontier BioSciences, Inc., with headquarters in Maryland, U.S.A., and toxicology facilities in Chengdu and Kunming, China, provides a full spectrum of drug discovery and development resources to biotechnology and pharmaceutical industries in the scientific disciplines of GLP-compliant toxicology, developmental and reproductive toxicology, pharmacology, genetic toxicology, pathology, analytical chemistry and international regulatory guidance.

For more information, contact:

Beth Wong
VP, Marketing and Business Development
Frontier BioSciences, Inc.
20251 Century Blvd, Suite 325
Germantown, MD 20874
301-515-5560